Osteoporosis is treated similarly in all patients with GFR greater than 30 mL/min. In patients with fragility fracture with a GFR less than 30 mL/min, correct diagnosis through biopsy and bone turnover markers of adynamic bone disease, hyperparathyroidism, osteomalacia, or osteoporosis is important because antiresorptive medications will not benefit a patient with adynamic bone disease.
Keywords: Chronic kidney disease mineral and bone disorders; Denosumab; End stage renal disease; Glomerular filtration rate; Osteomalacia; Osteoporosis.
Copyright © 2024 Elsevier Inc. All rights reserved.